Here is how GLP-1 can improve the weight loss process in people
doi: 10.3389/fphar.2025.1587314 Received 04 March 2025 Accepted 21 April 2025 Published 28 April 2025 Volume 16 - 2025 Edited by Ramzi Mothana, King Saud University, Saudi Arabia Reviewed by Jovana Rajkovic, University of Belgrade, Serbia Sidharth Mehan, Indo-Soviet Friendship College of Pharmacy, India Updates Copyright 2025 Jiang, Lhamo, Ma, Ye, Chen, He, Xu and Huang
The Alliance for Pharmacy Compounding (the compounding industry's own trade group) has told its members twice: do not compound retatrutide
Monitoring Storage Conditions: Invest in a reliable temperature monitoring system for your freezers
In the Times profile, Gallagher acknowledged that MEDVis initial site featured AI-generated photos and before-and-after weight loss images using faces swapped from photos found elsewhere online
What is already known on this topic Glucagon-like peptide-1 (GLP-1) receptor agonists and sodium-glucose cotransporter-2 (SGLT-2) inhibitors reduce the risk of cardiovascular and renal events in patients with type 2 diabetes These drug classes are increasingly used in combination when previous therapy with other antihyperglycaemic drugs fails Whether the combined use of these drug classes results in improved cardiovascular and renal outcomes in the real world setting, compared with the use of either drug class alone, remains unclear What this study adds This population based cohort study aimed at emulating a randomised controlled trial The combined use of a GLP-1 receptor agonist and an SGLT-2 inhibitor was associated with a lower risk of cardiovascular and serious renal events, compared with either drug class alone These findings highlight the potential benefit of combining these two effective drug classes in preventing cardiovascular and renal events in the treatment of type 2 diabetes Data availability statement This study is based on data from the Clinical Practice Research Datalink obtained under license from the UK Medicines and Healthcare products Regulatory Agency
